HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Nakaraang pagsara
$5.00
Sakop ng araw
$4.86 - $5.20
Sakop ng taon
$3.79 - $12.36
Market cap
2.22B USD
Average na Volume
61.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 19.22M | 33.34% |
Gastos sa pagpapatakbo | 46.65M | 46.56% |
Net na kita | -171.90M | -76.23% |
Net profit margin | -894.23 | -32.17% |
Kita sa bawat share | -0.41 | -2.50% |
EBITDA | -152.38M | -66.40% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 525.11M | 10.70% |
Kabuuang asset | 1.30B | 67.86% |
Kabuuang sagutin | 383.21M | 100.20% |
Kabuuang equity | 919.15M | — |
Natitirang share | 434.66M | — |
Presyo para makapag-book | 2.36 | — |
Return on assets | -33.79% | — |
Return on capital | -43.32% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -171.90M | -76.23% |
Cash mula sa mga operasyon | -76.42M | 7.06% |
Cash mula sa pag-invest | -5.81M | -38.88% |
Cash mula sa financing | 97.66M | -62.88% |
Net change in cash | 24.69M | -86.02% |
Malayang cash flow | -22.46M | 45.53% |
Tungkol
Itinatag
2013
Headquarters
Website
Mga Empleyado
800